Search - tctmd.com

Displaying 1 - 20 of 129

Sort: Relevancy | Date

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Daily News

Before a Cardiomyopathy Diagnosis, TTR Destabilization Portends Higher Mortality

Yael L. Maxwell

December 12, 2024

News Daily News

ACC Offers ‘Practical Document’ for Myocarditis Diagnosis and Care

Todd Neale

December 11, 2024

News Daily News

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Michael O'Riordan

December 06, 2024

News Daily News

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

L.A. McKeown

November 25, 2024

News Conference News AHA 2024

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

L.A. McKeown

November 22, 2024

News Conference News AHA 2024

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Yael L. Maxwell

November 20, 2024

News Conference News AHA 2024

First-line Catheter Ablation Works for Post-MI VT Suppression: VANISH2

Caitlin E. Cox

November 16, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

Presentation AHA 2024

Catheter Ablation or Antiarrhythmic Drug Therapy for Ventricular Tachycardia in Ischemic Cardiomyopathy: The VANISH2 Trial

Presenter: John Sapp

November 16, 2024

News Conference News TCT 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Yael L. Maxwell

November 07, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy

Presenter: Konstantinos Voudris

October 30, 2024

Presentation TCT 2024

TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy

Presenter: Stephen Ellis

October 29, 2024

Presentation TCT 2024

TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI

Presenter: Stephen Ellis

October 29, 2024

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

After REVIVED: When and How Should I Revascularize Patients With Cardiomyopathy and Coronary Artery Disease?

Presenter: Margaret McEntegart

October 29, 2024

Presentation TCT 2024

Case Presentation: Cardiogenic Shock in a Patient With Non-ischemic Cardiomyopathy

Presenter: Ann Gage

October 29, 2024

Advertisement

Top Heart Failure News of 2024

Top Structural Heart News of 2024

Before a Cardiomyopathy Diagnosis, TTR Destabilization Portends Higher Mortality

ACC Offers ‘Practical Document’ for Myocarditis Diagnosis and Care

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

First-line Catheter Ablation Works for Post-MI VT Suppression: VANISH2

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Catheter Ablation or Antiarrhythmic Drug Therapy for Ventricular Tachycardia in Ischemic Cardiomyopathy: The VANISH2 Trial

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy

TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy

TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

After REVIVED: When and How Should I Revascularize Patients With Cardiomyopathy and Coronary Artery Disease?

Case Presentation: Cardiogenic Shock in a Patient With Non-ischemic Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content